In addition to its well-known regulatory roles in mineral homeostasis, bone formation, and the endocrine system, the active
form of vitamin D exerts a wide range of modulatory functions in the immune response. Vitamin D receptor (VDR) agonists are
emerging as prominent candidates for immunotherapy, owing to their immunosuppressive effects on different cell-types of the
innate and adaptive branches of the immune system, including antigen presenting cells, T cells, and B cells. Recent work by
Geisler and colleagues, however, has uncovered an unexpected stimulatory effect of vitamin D3 on human T cells. In this article,
we focus on the mechanistic consequences of these new findings, with particular attention to possible novel therapeutic venues
that target the role of VDR in the function of T cells in the immunity of inflammation.